| | | GT repeat length | p-value |
|---|
Short | Long |
|---|
n (%) | n (%) |
|---|
Outcome | Died | 13 (59) | 23 (53) | 0.667 ¶ |
Discharge | 9 (41) | 20 (47) |
| | | Median (Range) | Median (Range) | |
PCT (ng/ml) | | 0.09 (0.01–0.42) | 0.3 (0.1–38) | 0.043† |
LDH (U/L) | | 659 (487–2805) | 307 (157–990) | 0.011† |
| | | Mean ± SD | Mean ± SD | |
D-dimer (ng/ml) | | 437 ± 290 | 1584 ± 1943 | 0.048§ |
CRP (mg/L) | | 197 ± 175 | 103 ± 88 | 0.003‡ |
HMOX-1 (µg/ml) | | 55.8 ± 21.3 | 60.5 ± 27.8 | 0.161 § |
- Table 3 summarizes the percentage of the short and long GT repeats alleles in survivors and patients who died as a result of COVID-19 disease. The concentrations of different markers evaluated in the study were stratified according to the GT repeat length whether short or long repeats. Normally distributed variables were expressed as Mean ± SD while abnormally distributed variables were expressed as Median (Range)
- CRP: C-Reactive protein, PCT: procalcitonin, LDH: Lactate dehydrogenase and HMOX-1: Hemoxygenase enzyme
- § : t-test
- † : Mann-Whitney test
- ¶ : Pearson
- ‡: Levene’s test
- Significant p-value: less than 0.05
